文献速递创伤与烧伤重症综合管理与镇静镇痛

连枷胸的手术稳定:患者选择、医院差异与结局

Surgical stabilization of flail chest: Patient selection, hospital variation, and outcomes.
PubMed 文献 · J Trauma Acute Care Surg · 2026-08-06
一句话结论连枷胸SSRF使用差异极大,30.1%中心不做;医院SSRF病例量高与更多无呼吸机天数、更短ICU和住院时间相关,而利用率高反与更差结局相关。

基于ACS-TQIP 2017-2020的回顾性队列研究,纳入≥18岁连枷胸患者。718家中心中216家(30.1%)未行SSRF;502家行SSRF的中心共15,380例连枷胸患者,3,484例(22.7%)接受SSRF。高龄(≥65岁)、女性、黑人种族、自费状态、创伤性脑损伤(AIS头≥3)与较低SSRF几率相关;肺挫伤、血胸、更高ISS与较高几率相关。医院间SSRF几率中位比值比3.08(95%CI 2.75-3.49)。医院SSRF病例量高与更多无呼吸机天数、更短ICU和住院时间相关,死亡率无差异;SSRF利用率高与更少无呼吸机天数、更长ICU和住院时间相关,死亡率无差异。

要点

  • 在502家行SSRF的创伤中心中,15,380例连枷胸患者仅3,484例(22.7%)接受SSRF,718家中心中216家(30.1%)完全不开展SSRF。
  • 高龄(≥65岁)、女性、黑人种族、自费状态、创伤性脑损伤(AIS头≥3)与较低SSRF几率相关;肺挫伤、血胸、更高ISS与较高几率相关。
  • 两家随机选择的医院中,条件相似患者接受SSRF的几率中位差异达3.08倍(95%CI 2.75-3.49),医院间差异显著。
  • 医院SSRF病例量越高,无呼吸机天数越多、ICU和住院时间越短,死亡率无差异。
  • 医院SSRF利用率(连枷胸患者中行SSRF比例)越高,无呼吸机天数越少、ICU和住院时间越长,死亡率无差异。

适用人群与场景

  • ACS-TQIP 2017-2020数据库中≥18岁连枷胸创伤患者。
  • 分析限于502家至少行1例SSRF的创伤中心;718家中心中216家(30.1%)未行SSRF,未纳入SSRF-performing分析。

诊断标准与关键阈值

  • 连枷胸诊断依据ACS-TQIP数据库记录;原文未提及具体诊断标准或阈值。
  • SSRF指手术稳定肋骨骨折;原文未提及具体手术指征或阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于ACS-TQIP 2017-2020的回顾性队列研究;718家中心治疗连枷胸,其中216家(30.1%)未行SSRF。
  • 502家行SSRF中心共15,380例连枷胸患者,3,484例(22.7%)接受SSRF。
  • SSRF预测因素:高龄(≥65岁)、女性、黑人种族、自费状态、创伤性脑损伤(AIS头≥3)与较低SSRF几率相关;肺挫伤、血胸、更高ISS与较高几率相关。
  • 医院间变异:中位比值比3.08(95%CI 2.75-3.49),即两家随机选择的医院中条件相似患者接受SSRF的几率中位差异为3.08倍。
  • 医院SSRF病例量高与更多无呼吸机天数、更短ICU和住院时间相关,死亡率无差异。
  • 医院SSRF利用率高与更少无呼吸机天数、更长ICU和住院时间相关,死亡率无差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(ACS-TQIP数据库),证据等级Level III,治疗/护理管理。
  • 局限:回顾性设计、数据库研究;原文未提及单中心、开放标签等;SSRF利用率与结局的关联可能受未测量混杂影响。

对床旁实践的改变

  • 连枷胸患者是否行SSRF在不同创伤中心差异极大(中位OR 3.08),提示患者选择标准不统一;床旁决策需注意本院常规。
  • 医院层面SSRF病例量高与更好结局(更多无呼吸机天数、更短ICU和住院时间)相关,死亡率无差异;利用率高反与更差结局相关,提示SSRF的院内使用模式可能影响结局。
  • 高龄(≥65岁)、女性、黑人种族、自费状态、创伤性脑损伤(AIS头≥3)患者接受SSRF几率较低,需注意是否存在选择偏倚。
  • 原文未提及具体适用/不适用人群、纳入/排除标准或药物剂量。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Surgical stabilization of rib fractures (SSRF) is increasingly used for flail chest, yet practice remains heterogeneous. We aimed to identify predictors of SSRF, quantify hospital-level variation, and evaluate whether hospital SSRF volume and utilization rate are associated with outcomes in flail chest.

METHODS: Using ACS-TQIP 2017 to 2020, we conducted a retrospective cohort study of trauma patients older than or equal to 18 years with flail chest. Mixed-effects logistic regression evaluated predictors of SSRF and between-hospital variation. Hospitals that performed ≥1 SSRF were grouped into quintiles by SSRF case volume and by SSRF utilization rate (proportion of flail chest patients undergoing SSRF), and associations with in-hospital mortality, 28-day ventilator-free days, ICU length of stay (LOS), and hospital LOS were assessed using adjusted regression models.

RESULTS: Among 718 centers treating flail chest, 216 (30.1%) did not perform SSRF. Among 15,380 flail chest patients treated at 502 SSRF-performing trauma centers, 3,484 (22.7%) underwent SSRF. Older age (≥65 y), female sex, Black race, self-pay status, and traumatic brain injury (AIS head ≥3) were associated with lower odds of SSRF; pulmonary contusion, hemothorax, and higher Injury Severity Score were associated with higher odds. Median odds ratio was 3.08 (95% CI: 2.75-3.49), indicating that for two otherwise similar patients treated at two randomly selected hospitals, the median difference in odds of receiving SSRF was 3.08-fold. Higher hospital SSRF volume was associated with more ventilator-free days and shorter ICU and hospital LOS without mortality differences. Higher SSRF utilization rate was associated with fewer ventilator-free days and longer ICU and hospital LOS without mortality differences.

CONCLUSIONS: SSRF use for flail chest varied widely across trauma centers. These findings suggest that not only whether patients receive SSRF, but also how hospitals use SSRF within their systems, may be critical to optimizing outcomes in flail chest.

LEVEL OF EVIDENCE: Level III, therapeutic/care management.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Karikis I, Olsen G, Hong M, et al. Surgical stabilization of flail chest: Patient selection, hospital variation, and outcomes. J Trauma Acute Care Surg. 2026. PMID: 42560998. doi:10.1097/TA.0000000000005156

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。